Endpoints News
Boehringer’s Tradjenta is first drug selected for renegotiations Read in browser
Endpoints News
ALERT
Thank you for reading, dupa dupackia!
basic
UPGRADE
Breaking News

An­oth­er GLP-1 drug is up for Medicare ne­go­ti­a­tions un­der the In­fla­tion Re­duc­tion Act. Eli Lil­ly’s di­a­betes drug Trulic­i­ty is among 15 drugs se­lect­ed for the third round of ne­go­ti­a­tions...

Read the full story
Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com
web twitter linkedin
Worldwide made. Thanks for reading.
Unsubscribe preferences
Unsubscribe from all newsletters
FT Specialist Logo A service from the Financial Times